CDK4 and glioblastoma: An increased expression of CDK4 in the peritumoural margin of GBM seemed to reduce the overall survival of these patients, as observed in Figure 3 (hazard ratio: 5.278, confident interval: 0.8991 to 30.99, p = 0.050).